EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The use of respiratory rate-oxygenation index to predict failure of high-flow nasal cannula in patients with coronavirus disease 2019-associated acute respiratory distress syndrome: A retrospective study

Sujaree Poopipatpab iD, Pruchwilai Nuchpramool, Piyarat Phairatwet, Todspol Lertwattanachai, Konlawij Trongtrakul iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0287432 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Sujaree Poopipatpab und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand. Hauptthemen laut MEDLINE: COVID-19, Respiratory Insufficiency, Respiratory Distress Syndrome, Noninvasive Ventilation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Navamindradhiraj University Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with mild-to-moderate coronavirus disease 2019 (COVID-19)-associated acute respiratory distress syndrome (ARDS) can be treated with a high-flow nasal cannula (HFNC). The use of the respiratory rate-oxygenation (ROX) index, calculated as the ratio of oxygen saturation (SpO 2 )/fractional oxygen (FiO 2 ) to respiratory rate, in the first few hours after HFNC initiation can help identify patients who fail HFNC therapy later. However, few studies have documented the use of the ROX index during the period of HFNC therapy. Therefore, we aimed to demonstrate the diagnostic performance of the ROX index when calculated throughout the HFNC therapy period and to determine the best cut-off point for predicting HFNC failure. We conducted a retrospective study of patients with COVID-19-associated ARDS who commenced HFNC at the Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Thailand, between April 1 and August 30, 2021. We calculated the ROX index every 4 h throughout the HFNC therapy period and defined HFNC failure as a subsequent endotracheal tube intubation. The performance of the ROX index was analyzed using the area under the receiver operating characteristic curve (AUC). We applied the ROX index ≤ 4.88 to predict HFNC failure and obtained a new ROX cut-off point using Youden’s method. In total, 212 patients with COVID-19 treated with HFNC were included in the study. Of these, 81 patients (38.2%) experienced HFNC failure. The ROX index ≤ 4.88 demonstrated a reasonable performance in predicting HFNC failure (AUC, 0.77; 95% confidence interval [CI], 0.72–0.83; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Respiratory InsufficiencyRespiratory Distress SyndromeNoninvasive VentilationHumansCannulaRetrospective StudiesRespiratory RateOxygen Inhalation TherapyIntubation, Intratracheal

Autor:innen und Institutionen

  • Department of Anesthesiology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.
  • Department of Internal Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.
  • Department of Pharmacology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.
  • Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

ORCID-Profile: Sujaree Poopipatpab, Konlawij Trongtrakul

Förderung

  • The Navamindradhiraj University Research Fund

Zitieren

APA

Poopipatpab, S., Nuchpramool, P., Phairatwet, P., Lertwattanachai, T., & Trongtrakul, K. (2023). The use of respiratory rate-oxygenation index to predict failure of high-flow nasal cannula in patients with coronavirus disease 2019-associated acute respiratory distress syndrome: A retrospective study. PLOS ONE. https://doi.org/10.1371/journal.pone.0287432

Vancouver

Poopipatpab S, Nuchpramool P, Phairatwet P, Lertwattanachai T, Trongtrakul K. The use of respiratory rate-oxygenation index to predict failure of high-flow nasal cannula in patients with coronavirus disease 2019-associated acute respiratory distress syndrome: A retrospective study. PLOS ONE. 2023. doi:10.1371/journal.pone.0287432

BibTeX
@article{Poopipatpab2023,
  author = {Poopipatpab, Sujaree and Nuchpramool, Pruchwilai and Phairatwet, Piyarat and Lertwattanachai, Todspol and Trongtrakul, Konlawij},
  title = {The use of respiratory rate-oxygenation index to predict failure of high-flow nasal cannula in patients with coronavirus disease 2019-associated acute respiratory distress syndrome: A retrospective study},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0287432}
}
Kostenlos starten →